Primary hyperparathyroidism regression associated to cinacalcet therapy proved by 99mTc-MIBI scintigraphy

被引:1
作者
Coloma, A. [1 ]
Hernandez-Estrada, S. [1 ]
Bowles, H. [2 ]
Sanchez, N. [2 ]
Fuster, D. [2 ]
Torregrosa, J. [1 ]
机构
[1] Hosp Clin Barcelona, Renal Transplant Unit, Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Nucl Med, Barcelona, Spain
来源
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR | 2017年 / 36卷 / 02期
关键词
D O I
10.1016/j.remn.2016.10.010
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:120 / 121
页数:2
相关论文
共 3 条
[1]   Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects [J].
Duntas, Leonidas H. ;
Stathatos, Nikolaos .
ENDOCRINE, 2011, 39 (03) :199-204
[2]   Dual-phase 99mTc-MIBI scintigraphy to assess calcimimetic effect in patients on haemodialysis with secondary hyperparathyroidism [J].
Fuster, David ;
Torregrosa, Jose-Vicente ;
Domenech, Beatriz ;
Sola, Oriol ;
Martin, Gloria ;
Casellas, Joan ;
Setoain, Xavier ;
Muxi, Africa ;
Pons, Francesca .
NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (11) :890-894
[3]   Medical Management of Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism [J].
Marcocci, Claudio ;
Bollerslev, Jens ;
Khan, Aliya Aziz ;
Shoback, Dolores Marie .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10) :3607-3618